(Total Views: 184)
Posted On: 07/06/2022 11:03:23 AM
Post# of 44968
$JUPW Jupiter Wellness Developing Novel Women’s Sexual Health Product
JUPITER, FL / ACCESSWIRE / July 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it is developing RJ-101 a new product with a novel mechanism of action in the women's sexual wellness category. It is covered by 2 issued patents, US #10,357,452 and US #10,064,816, RJ-101 when applied to the nipple-areola area of the breast contracts the smooth muscle thus erecting the nipple and increasing its sensitivity. Through the recent acquisition of Applied Biology assets, Jupiter Wellness holds a broad IP position on the use of topical alpha-1 agonists for the treatment of sexual dysfunction. Clinical trials have shown efficacy and safety in improving female nipple sensitivity and concomitantly enhanced sexual arousal, lubrication, and orgasm in pre- and post-menopausal women.
https://finance.yahoo.com/news/jupiter-wellne...00608.html
JUPITER, FL / ACCESSWIRE / July 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it is developing RJ-101 a new product with a novel mechanism of action in the women's sexual wellness category. It is covered by 2 issued patents, US #10,357,452 and US #10,064,816, RJ-101 when applied to the nipple-areola area of the breast contracts the smooth muscle thus erecting the nipple and increasing its sensitivity. Through the recent acquisition of Applied Biology assets, Jupiter Wellness holds a broad IP position on the use of topical alpha-1 agonists for the treatment of sexual dysfunction. Clinical trials have shown efficacy and safety in improving female nipple sensitivity and concomitantly enhanced sexual arousal, lubrication, and orgasm in pre- and post-menopausal women.
https://finance.yahoo.com/news/jupiter-wellne...00608.html
(0)
(0)
